These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 25591512)

  • 1. [Efficacy of the combination drug vasobral in chronic vascular encephalopathy].
    Levin OS; Barantsevich ER; Belskaya GN; Vasenina EE; Kopishinskaya SV; Lukashevich IG; Ostroumova OD; Psokhina OV; Radiuk MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(10):25-9. PubMed ID: 25591512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preventive treatment of migraine with vasobral: a multicenter trial].
    Tabeeva GR; Azimova IuE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 2):26-30. PubMed ID: 21389936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vasobral in the treatment of initial atherosclerotic circulatory encephalopathy].
    Shprakh VV; Molokov DD; Tatarinova MB; Burdukovskaia NL
    Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(2):39-40. PubMed ID: 8754338
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vasobral and stabilized cerebral vascular complication: hemodynamic and psychometric study].
    Poncin-Lafitte M; Migeon P; Rancurel G; Rapin JR
    Ann Radiol (Paris); 1987; 30(6):425-30. PubMed ID: 3129979
    [No Abstract]   [Full Text] [Related]  

  • 5. [The influence of alpha-dihydroergocryptine derivatives on psychomotor manifestations in Parkinson disease].
    Sadekov RA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(12):43-5. PubMed ID: 11195537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vasobral in the treatment of brain lesions: views of physicians and patients].
    Kamchatnov PR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(1):23-5. PubMed ID: 23528488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience in the administration of vasobral in sensorineural vascular hypoasusis].
    Grinshteĭn AB; Shnaĭder NA; Kromm OK; Pavlovskaia MV
    Vestn Otorinolaringol; 2001; (2):39-41. PubMed ID: 11338557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of quality of life and treatment adherence in patients with dizziness treated with vasobral].
    Lebedeva AV; Kamchatnov PR; Burd SG; Prikazchikov SV; Cherkasova AE; Solovyeva TY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(2):28-34. PubMed ID: 30874523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of vasobral in therapy of central nervous system pathology in children of early age].
    Zaĭtseva IN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(1):92-4. PubMed ID: 20614656
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of vasobral in patients with chronic cerebrovascular disorders].
    Kamchatnov PR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 1):70-2. PubMed ID: 22500318
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibition of post-partum physiological milk secretion by caffeine dihydroergocryptine and dihydroergotoxine].
    Elsener M; Ferrafiat M; de Bruyn M; Jouhet P; Robert Y; Rouge PE
    Rev Fr Gynecol Obstet; 1988 Nov; 83(11):697-701. PubMed ID: 3144727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the effectiveness of dihydroergotoxine (DHET) in the treatment of chronic cerebral ischemia syndromes in elderly patients].
    Derejczyk J; Panuś K
    Wiad Lek; 1986 Jun; 39(12):818-24. PubMed ID: 3535261
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinico-rheographic study of the cerebrovascular effect of alpha-adrenergic blockers in vascular diseases of the brain].
    Shtok VN; Varlamova IV; Fedorova NV; Timurbaator
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1333-8. PubMed ID: 4072531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of cytoflavin in patients with hypertonic encephalopathy and constitutional venous insufficiency].
    Belova LA; Mashin VV; Kolotik-Kameneva OIu; Belova NV; Byrina AV; Evstigneeva AIu; Abramova VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):21-6. PubMed ID: 23096033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydroergocryptine in the management of senile psycho-organic syndrome.
    Scarzella L; Bono G; Bergamasco B
    Int J Clin Pharmacol Res; 1992; 12(1):37-46. PubMed ID: 1526697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An open clinical trial of cortexin in treatment of brain ischemia].
    Mashin VV; Belova LA; Chaplanova OI; Khusnullina AF; Manasian AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(9):49-52. PubMed ID: 25403301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of vazobral in chronic cerebral ischemia and headache].
    Parfenov VA; Pozhidaev KA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(9):126-129. PubMed ID: 30335084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic effectiveness and safety of dihydroergocristine. A study of 9,702 patients].
    Mailland F; Zottino G
    Fortschr Med; 1986 Mar; 104(11):239-42. PubMed ID: 3084366
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dynamics of the symptoms of chronic ischemia during the treatment with cytoflavin].
    Madzhidova EN; Usmanova DD; Baĭtursunova ZhM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):57-62. PubMed ID: 23235414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertension therapy with Briserin: what role do dihydroergocristine components play?].
    Schardt F; Polzien P
    Med Klin; 1981 Dec; 76(26):746-52. PubMed ID: 6798382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.